(Q43290574)
Statements
Randomized phase II study comparing two schedules of everolimus in patients with recurrent/metastatic breast cancer: NCIC Clinical Trials Group IND.163 (English)
Karen A Gelmon
Brian Norris
Hagen Kennecke
Stephen Chia
Andrea Eisen
Ted Vandenberg
Marianne Taylor
Eric Sauerbrei
Moshe Mishaeli
David Huntsman
Wendy Walsh
Martin Olivo
Lynn McIntosh